Free tool
Cell therapy stocks
We cover 3 companies grouped under the Cell therapy theme. The median market value in the group is $18.02M. Across the group, the median move over the past trading day is +0.71%. Price change over the past year runs from −78.3% to −28.6% across the middle 80 percent of the group, with a median of −38.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 4584.T | Kidswell Bio Corporation | 179.00 JPY | +29.71% | −15.57% | −26.03% |
| BCDA | BioCardia, Inc. | $1.19 | +52.56% | −6.30% | −38.66% |
| FBLG | FibroBiologics, Inc. | $1.41 | +116.92% | −70.62% | −88.25% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.